By using this model, we showed the development of MUC1-expressing colorectal tumors in an environment and immune system that recognizes MUC1 as a self (de novo) antigen and closely mimics the colitis-associated colorectal carcinogenesis conditions as seen in humans. The gene discussed is MUC1; the disease is colitis.